0001889938-26-000002.txt : 20261119 0001889938-26-000002.hdr.sgml : 20261119 20261119152400 ACCESSION NUMBER: 0001889938-26-000002 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20261119 DATE AS OF CHANGE: 20261119 EFFECTIVENESS DATE: 20261119 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Anuncia Medical, Inc. CENTRAL INDEX KEY: 0001889938 ORGANIZATION NAME: EIN: 824114865 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-523914 FILM NUMBER: 261574394 BUSINESS ADDRESS: STREET 1: 1355 N. SCOTTSDALE RD STREET 2: SUITE 370 CITY: SCOTTSDALE STATE: AZ ZIP: 85257 BUSINESS PHONE: (513)-500-6736 MAIL ADDRESS: STREET 1: 1355 N. SCOTTSDALE RD STREET 2: SUITE 370 CITY: SCOTTSDALE STATE: AZ ZIP: 85257 FORMER COMPANY: FORMER CONFORMED NAME: Anuncia, Inc. DATE OF NAME CHANGE: 20211022 D/A 1 primary_doc.xml X0708 D/A LIVE 0001889938 Anuncia Medical, Inc. 10446 N. 74th St. Suite 120 SCOTTSDALE AZ ARIZONA 85258 (513) 500-6736 DELAWARE Anuncia, Inc. Corporation true Elsa Abruzzo 10446 N. 74th St. Suite 120 Scottsdale AZ ARIZONA 85258 Executive Officer Director PJ Anand 10446 N. 74th St. Suite 120 Scottsdale AZ ARIZONA 85258 Director Richard Upton 10446 N. 74th St. Suite 120 Scottsdale AZ ARIZONA 85258 Director Edgar D Janotta 10446 N. 74th St. Suite 120 Scottsdale AZ ARIZONA 85258 Director Stephen Oesterle 10446 N. 74th St. Suite 120 Scottsdale AZ ARIZONA 85258 Director Stanton Rowe 10446 N. 74th St. Suite 120 Scottsdale AZ ARIZONA 85258 Director Ghassan Kassab 10446 N. 74th St. Suite 120 Scottsdale AZ ARIZONA 85258 Director Darryl Baker 10446 N. 74th St. Suite 120 Scottsdale AZ ARIZONA 85258 Executive Officer Biotechnology Decline to Disclose 06b true 0001889938-25-000002 2024-08-30 false true true true false 0 U.S. Boston Capital Corporation 5251 None None 55 Old Bedford Road Suite 202 Lincoln MA MASSACHUSETTS 01773 All States false 18372472 16213083 2159389 Amounts include conversion of outstanding promissory notes. In addition, the Company has offered 5-year warrants to purchase up to a maximum of 886,839 shares at $0.2819 per share. false 102 0 66450 450000 true false Anuncia Medical, Inc. /s/ Elsa Abruzzo Elsa Abruzzo President and CEO 2026-11-19